Publications

Optimizing the Use of Cabotegravir Plus Rilpivirine Long-Acting Therapy in Hiv Care: Evidence, Implementation, and Unanswered Questions

AuthID
P-019-NAQ

Author(s)

Geretti, AM

Boffito, M

Bonora, S

Braun, P

Charpentier, C

Garcia, F

Ghosn, J

Gomes, P

Marcelin, AG

Mesplede, T

Parczewski, M

Ring, K

Santoro, MM

Solas, C

Wolf, E

Orkin, C

Document Type

Review

Year published

2025

Published

in OPEN FORUM INFECTIOUS DISEASES, ISSN: 2328-8957

Volume: 12, Issue: 7

Indexing

Wos^®

Crossref^®

Pubmed^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1093/ofid/ofaf368

Pubmed: 40735332

Wos: WOS:001537456700001

Source Identifiers

ISSN: 2328-8957

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Optimizing the Use of Cabotegravir Plus Rilpivirine Long-Acting Therapy in Hiv Care: Evidence, Implementation, and Unanswered Questions

Useful Links

Get Help

Federated Authentication (Click on the image)

Optimizing the Use of Cabotegravir Plus Rilpivirine Long-Acting Therapy in Hiv Care: Evidence, Implementation, and Unanswered Questions

Useful Links

Get Help